| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |